tradingkey.logo
搜尋

Stereotaxis Inc

STXS
添加自選
1.260USD
-0.070-5.26%
收盤 07-31 16:00美東報價延遲15分鐘
114.77M總市值
虧損本益比TTM

關於 Stereotaxis Inc 公司

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.

Stereotaxis Inc簡介

公司代碼STXS
公司名稱Stereotaxis Inc
上市日期Aug 12, 2004
CEOFischel (David Leo)
員工數量139
證券類型Ordinary Share
年結日Aug 12
公司地址710 N Tucker Blvd
城市ST. LOUIS
上市交易所NASDAQ OMX – NASDAQ Basic Amex
國家United States of America
郵編63101
電話13146786100
網址https://www.stereotaxis.com/
公司代碼STXS
上市日期Aug 12, 2004
CEOFischel (David Leo)

Stereotaxis Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. David W. Benfer
Mr. David W. Benfer
Lead Independent Director
Lead Independent Director
506.41K
+8.51%
Dr. Nathan Fischel, M.D.
Dr. Nathan Fischel, M.D.
Director
Director
297.60K
+14.48%
Mr. David Leo Fischel
Mr. David Leo Fischel
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
255.00K
+21.57%
Mr. Ross B. Levin
Mr. Ross B. Levin
Independent Director
Independent Director
198.08K
+21.76%
Mr. Nachum (Homi) Shamir
Mr. Nachum (Homi) Shamir
Director
Director
179.33K
+24.04%
Dr. Arun Swarup Menawat, Ph.D.
Dr. Arun Swarup Menawat, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kimberly R. Peery
Ms. Kimberly R. Peery
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Myriam J. Curet, M.D.
Dr. Myriam J. Curet, M.D.
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. David W. Benfer
Mr. David W. Benfer
Lead Independent Director
Lead Independent Director
506.41K
+8.51%
Dr. Nathan Fischel, M.D.
Dr. Nathan Fischel, M.D.
Director
Director
297.60K
+14.48%
Mr. David Leo Fischel
Mr. David Leo Fischel
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
255.00K
+21.57%
Mr. Ross B. Levin
Mr. Ross B. Levin
Independent Director
Independent Director
198.08K
+21.76%
Mr. Nachum (Homi) Shamir
Mr. Nachum (Homi) Shamir
Director
Director
179.33K
+24.04%
Dr. Arun Swarup Menawat, Ph.D.
Dr. Arun Swarup Menawat, Ph.D.
Independent Director
Independent Director
--
--

常見問題

Stereotaxis Inc的前五大股東是誰?

Stereotaxis Inc的前五大股東如下:Mr. David W. Benfer

有多少機構持有Stereotaxis Inc(STXS)的股份?

截至2026Q1,共有205家機構持有Stereotaxis Inc的股份,合計持有的股份價值約為49.70M,占公司總股份的50.99% 。與2025Q4相比,機構持股有所增加,增幅為2238158.00。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有